Director of Castle Biosciences Inc (NASDAQ:CSTL), Bradbury Daniel, sells 3,750 shares worth $221,099
According to Castle Biosciences Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 14 01:52 PM, company Director, Bradbury Daniel disclosed selling 3,750 shares at a cost of $58.96. At the time of this transaction (Dec 10), this trade was worth $221,099 in total. As of Dec 10, Bradbury Daniel now owns 767,828 shares in total worth about $48,004,606.56.
For the last few recent trades made by Castle Biosciences Inc (NASDAQ:CSTL) Director, Bradbury Daniel, we have the following information:
- SEC Form 4 filing: Dec 11: Sold 6,637 shares at the rate of $60.07 per share. Total worth of this trade was $398,711. Total number of shares owned as of Dec 11 were 761,191
- SEC Form 4 filing: Oct 20: Sold 11,750 shares at the rate of $49.70 per share. Total worth of this trade was $583,948. Total number of shares owned as of Oct 20 were 791,828
- SEC Form 4 filing: Oct 21: Sold 5,250 shares at the rate of $48.69 per share. Total worth of this trade was $255,648. Total number of shares owned as of Oct 21 were 786,578
Posted by
George Daniels
on Monday December 14 2020, 4:24 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
